We hypothesise that ATG4B dysregulation could compromise cell survival in a stress situation due to a lack of autophagy and deLC3ylation activity, becoming an excellent potential target for ALS therapy. This evidence concerns the gene ATG4B and amyotrophic lateral sclerosis.